Jennifer Gray
Family Medicine · Bowling Green, KYNPI 1649253527
Payments from drug & device makers
Across 146 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$642
- AstraZeneca$329
- AbbVie$284
- Novo Nordisk$246
- Merck$169
- Insulet Corporation$142
- plus $931 from 20 others
What the payments were for
- Food & beverage$2,743100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 24 | $642 |
| AstraZeneca | 13 | $329 |
| AbbVie(2 entities) | 22 | $284 |
| Novo Nordisk | 21 | $246 |
| Merck | 12 | $169 |
| Insulet Corporation | 4 | $142 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Pfizer | 5 | $92 |
| Amgen | 5 | $84 |
| Sanofi-aventis U.S. LLC | 3 | $75 |
| Novartis | 4 | $72 |
| Lilly USA, LLC | 5 | $66 |
| Amarin Pharma, Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Johnson & Johnson | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Sanofi Pasteur Inc. | 2 | $32 |
| Boehringer Ingelheim | 1 | $32 |
| Astellas Pharma US Inc | 2 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $26 |
| Bayer | 1 | $26 |
| Biogen | 1 | $26 |
| Mylan Specialty L.p. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEXSERO$249
How this compares
$2,743 in reported general payments places this provider in the 75th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $44,304 |
| JardianceEmpagliflozin | 49 | $43,142 |
| EliquisApixaban | 43 | $41,048 |
| FarxigaDapagliflozin Propanediol | 28 | $31,594 |
| JanuviaSitagliptin Phosphate | 32 | $26,764 |
| LinzessLinaclotide | 38 | $26,552 |
| OzempicSemaglutide | 22 | $21,735 |
| VraylarCariprazine Hcl | 15 | $21,161 |
| RexultiBrexpiprazole | 12 | $19,470 |
| Breo ElliptaFluticasone/Vilanterol | 47 | $19,260 |
| MyrbetriqMirabegron | 23 | $15,831 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $13,696 |
| TradjentaLinagliptin | 13 | $13,071 |
| XareltoRivaroxaban | 11 | $11,869 |
| EntrestoSacubitril/Valsartan | 11 | $10,173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $642 | $73,598116 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $32 | $66,04382 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $329 | $50,85559 claims |
| AbbVieLinzess, Vraylar | $284 | $47,71353 claims |
| PfizerEliquis | $92 | $41,04843 claims |
| MerckJanuvia | $169 | $26,76432 claims |
| Novo NordiskOzempic | $246 | $21,73522 claims |
| Astellas Pharma US IncMyrbetriq | $28 | $15,83123 claims |
| Johnson & JohnsonXarelto | $41 | $11,86911 claims |
| NovartisEntresto | $72 | $10,17311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Bowling Green
- Diego MastronardiBowling Green$196K
- Jane GibsonBowling Green$49K
- John TappBowling Green$25K
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- James TurnboPaducah$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.